Skip to main content

SEQUOIA A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CK-3773274 IN ADULTS WITH SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY AND LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION

Clinical Trial Grant
Duke Scholars

Administered By

Institutes and Centers

Awarded By

Cytokinetics, Inc.

Start Date

February 28, 2022

End Date

March 1, 2024
 

Administered By

Institutes and Centers

Awarded By

Cytokinetics, Inc.

Start Date

February 28, 2022

End Date

March 1, 2024